We are live on ! Find out more
EXEL icon

Exelixis

344 hedge funds and large institutions have $4.82B invested in Exelixis in 2021 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 117 increasing their positions, 123 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.41% more ownership

Funds ownership: 84.05%85.46% (+1.4%)

0% more call options, than puts

Call options by funds: $20.1M | Put options by funds: $20.1M

1% less funds holding

Funds holding: 347344 (-3)

2% less first-time investments, than exits

New positions opened: 42 | Existing positions closed: 43

5% less repeat investments, than reductions

Existing positions increased: 117 | Existing positions reduced: 123

18% less capital invested

Capital invested by funds: $5.9B → $4.82B (-$1.09B)

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
344
Holders Change
-3
Holders Change %
-0.86%
% of All Funds
5.99%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
42
Increased
117
Reduced
123
Closed
43
Calls
$20.1M
Puts
$20.1M
Net Calls
+$7K
Net Calls Change
-$5.96M

EXEL Hedge Fund Activity: Q2 2021 in Review

344 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q2 2021, worth a combined $4.82B — down 18% from $5.9B a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of EXEL and 42 opened new positions — a net loss of 1 holder — while 123 trimmed existing stakes and 117 added.

The largest buyer was Fidelity Investments, adding an estimated $115M. The largest seller was T. Rowe Price Associates, cutting an estimated $24.7M.

  • 344 institutional investors held Exelixis (EXEL) as of Q2 2021, down from 347 in Q1 2021.
  • Funds reported $4.82B of Exelixis stock for Q2 2021, down 18% quarter-over-quarter.
  • 42 funds opened new Exelixis positions in Q2 2021 and 43 closed out, a net change of -1 holder.
  • The largest Exelixis buyer in Q2 2021 was Fidelity Investments, an estimated $115M added.
  • The largest Exelixis seller in Q2 2021 was T. Rowe Price Associates, an estimated $24.7M sold.

Based on aggregated 13F filings for Q2 2021.